Adasuve
These highlights do not include all the information needed to use ADASUVE safely and effectively. See full prescribing information for ADASUVE. ADASUVE (loxapine) inhalation powder, for oral inhalation use Initial U.S. Approval: 1975
Approved
Approval ID
50e11732-7387-452d-b3e6-db3a431d5c4a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 9, 2024
Manufacturers
FDA
Alexza Pharmaceuticals, Inc.
DUNS: 018849948
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
loxapine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51097-001
Application NumberNDA022549
Product Classification
M
Marketing Category
C73594
G
Generic Name
loxapine
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateJanuary 9, 2024
FDA Product Classification
INGREDIENTS (1)
LOXAPINEActive
Quantity: 10 mg in 1 1
Code: LER583670J
Classification: ACTIB